These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3541882)

  • 81. Treatment with histamine H2 antagonists in acute upper gastrointestinal hemorrhage. Implications of randomized trials.
    Collins R; Langman M
    N Engl J Med; 1985 Sep; 313(11):660-6. PubMed ID: 2862581
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A comparison of 4-week peptic ulcer healing rates following treatment with antacids and ranitidine.
    Bezuidenhout DJ; Perold JG; Adams G
    S Afr Med J; 1984 Jun; 65(25):1007-9. PubMed ID: 6328685
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Mortality from bleeding peptic ulcer. Alfred Hospital, Melbourne, 1976-1980.
    McDermott FT
    Med J Aust; 1985 Jan; 142(1):11-4. PubMed ID: 3965865
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Neodymium yttrium aluminium garnet laser photocoagulation for major haemorrhage from peptic ulcers and single vessels: a single blind controlled study.
    MacLeod IA; Mills PR; MacKenzie JF; Joffe SN; Russell RI; Carter DC
    Br Med J (Clin Res Ed); 1983 Jan; 286(6362):345-8. PubMed ID: 6402091
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Standards for bleeding ulcer in the upper gastrointestinal tract].
    Mössner J; Caca K
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S64-8. PubMed ID: 12817325
    [No Abstract]   [Full Text] [Related]  

  • 86. [Risk factors of complications of peptic ulcer by acute hemorrhage and perforation].
    Bachev II
    Vestn Khir Im I I Grek; 1991 Feb; 146(2):20-4. PubMed ID: 1652827
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Intermittent versus continuous pantoprazole infusion in peptic ulcer bleeding: a prospective randomized study.
    Yüksel I; Ataseven H; Köklü S; Ertuğrul I; Başar O; Odemiş B; Ibiş M; Saşmaz N; Sahin B
    Digestion; 2008; 78(1):39-43. PubMed ID: 18824852
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prophylactic treatment of acute gastroduodenal stress ulceration. Low-dose antacid treatment without and with additional ranitidine.
    Koelz HR; Aeberhard P; Hassler H; Kunz H; Wagner HE; Roth F; Halter F
    Scand J Gastroenterol; 1987 Nov; 22(9):1147-52. PubMed ID: 3321397
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Non-endoscopic first-line treatment of bleeding peptic ulcer with ranitidine and tranexamic acid.
    Breckan RK; Wessel-Berg AM; Jorde R
    Scand J Gastroenterol; 2003 Sep; 38(9):1000-1. PubMed ID: 14531540
    [No Abstract]   [Full Text] [Related]  

  • 90. Prostaglandins and clinical experience in peptic ulcer disease.
    Lauritsen K; Rask-Madsen J
    Scand J Gastroenterol Suppl; 1986; 125():174-80. PubMed ID: 3547613
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Prophylaxis with ranitidine against peptic ulcer disease after liver transplantation.
    Klompmaker IJ; Slooff MJ; de Bruijn KM; Sluiter WJ; Bams JL
    Transpl Int; 1988 Dec; 1(4):209-12. PubMed ID: 3075484
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Efficiency of a novel gel product for duodenal ulcer bleeding.
    Miyamoto S; Suzuki K; Kinoshita K
    Dig Endosc; 2021 May; 33(4):e63-e64. PubMed ID: 33764564
    [No Abstract]   [Full Text] [Related]  

  • 93. Bleeding duodenal uicer: study of one hundred sixty-two patients, with particular reference to pain, seasonal incidence, and blood groups.
    BANDLER M; DESJARDINS JA
    J Am Med Assoc; 1959 Aug; 170():2174-7. PubMed ID: 13796379
    [No Abstract]   [Full Text] [Related]  

  • 94. Optimal placebo response rates for comparing two binomial proportions.
    Day SJ
    Stat Med; 1988 Nov; 7(11):1187-94. PubMed ID: 2974173
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical evaluation of dhatrilauha in parinamasula.
    Gupta PK; Shukla KP; Gupta JP
    Anc Sci Life; 1998 Jul; 18(1):3-18. PubMed ID: 22556862
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Ranitidine and duodenal ulceration.
    Roberts DM
    J R Soc Med; 1982 Sep; 75(9):754-5. PubMed ID: 20894432
    [No Abstract]   [Full Text] [Related]  

  • 97. Ranitidine: patients taking certain batches should "immediately discontinue use," says FDA.
    Mahase E
    BMJ; 2019 Dec; 367():l7053. PubMed ID: 31857287
    [No Abstract]   [Full Text] [Related]  

  • 98. Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.
    Grant SM; Langtry HD; Brogden RN
    Drugs; 1989 Jun; 37(6):801-70. PubMed ID: 2667937
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Controlled clinical trial of ranitidine in bleeding peptic ulcer.
    Gray BN; De Zwart J; Andrewarthur L; Crowley S; Kamm M; Watson K
    Aust N Z J Surg; 1986 Sep; 56(9):723-7. PubMed ID: 3541882
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Histamine2-receptor antagonists in gastroduodenal ulcer haemorrhage.
    Falk A; Darle N; Haglund U; Törnqvist A
    Scand J Gastroenterol Suppl; 1985; 110():95-100. PubMed ID: 2862700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.